Abstract
Intelligence predicts important life and health outcomes, but the biological mechanisms underlying differences in intelligence are not yet understood. The use of genetically determined metabotypes (GDMs) to understand the role of genetic and environmental factors, and their interactions, in human complex traits has been recently proposed. However, this strategy has not been applied to human intelligence. Here we implemented a two-sample Mendelian randomization (MR) analysis using GDMs to assess the causal relationships between genetically determined metabolites and human intelligence. The standard inverse-variance weighted (IVW) method was used for the primary MR analysis and three additional MR methods (MR-Egger, weighted median, and MR-PRESSO) were used for sensitivity analyses. Using 25 genetic variants as instrumental variables (IVs), our study found that 5-oxoproline was associated with better performance in human intelligence tests (P<sub>IVW</sub> = 9.25×10<sup>-5</sup>). The causal relationship was robust when sensitivity analyses were applied (P<sub>MR-Egger</sub> = 0.0001, P<sub>Weighted median</sub> = 6.29×10<sup>-6</sup>, P<sub>MR-PRESSO</sub> = 0.0007), and repeated analysis yielded consistent result (P<sub>IVW</sub> = 0.0087). Similarly, also dihomo-linoleate (20:2n6) and p-acetamidophenylglucuronide showed robust association with intelligence. Our study provides novel insight by integrating genomics and metabolomics to estimate causal effects of genetically determined metabolites on human intelligence, which help to understanding of the biological mechanisms related to human intelligence.
Introduction
Human intelligence is a highly heritable trait and a significant predictor of various life outcomes, including educational attainment, socioeconomic status, and health. Despite its importance, the specific biological mechanisms that drive individual differences in cognitive ability remain largely unknown. Most existing research has relied on observational studies, which are limited by potential confounding factors and the inability to establish definitive causal relationships. For example, it is often unclear whether a specific metabolic profile enhances intelligence or if individuals with higher cognitive abilities adopt lifestyles that alter their metabolism.
To overcome these challenges, this study utilizes Mendelian randomization (MR), a method that uses genetic variants as instrumental variables to infer causal relationships between exposures (metabolites) and outcomes (intelligence). By focusing on genetically determined metabotypes (GDMs), we can treat genetic inheritance as a natural experiment, providing a clearer picture of how our internal chemistry shapes cognitive function.
Methods
The researchers employed a two-sample Mendelian randomization framework, integrating several large-scale datasets. Metabolomics data were sourced from a genome-wide association study (GWAS) of 486 metabolites in 7,824 healthy adults. Intelligence data were obtained from a meta-analysis of GWAS results involving 269,867 individuals of European ancestry.
To ensure the reliability of the causal inferences, the study utilized four distinct statistical models: Inverse-Variance Weighted (IVW) as the primary method, along with MR-Egger, weighted median, and MR-PRESSO as sensitivity analyses. These additional models are crucial for detecting and correcting for pleiotropy—a phenomenon where a single genetic variant affects multiple unrelated traits, which can lead to biased results. The findings were further validated using independent replication datasets, including the UK Biobank (248,482 samples) and cohorts focused on cognitive performance and educational attainment.
Results
The most significant finding was the positive causal association between 5-oxoproline (also known as pyroglutamic acid) and intelligence. Higher genetically predicted levels of 5-oxoproline were consistently linked to higher intelligence scores across all statistical models. For every standard deviation increase in 5-oxoproline, there was a corresponding 0.24 increase in the Spearman’s g (intelligence) score. This relationship was successfully replicated in independent datasets for both intelligence and general cognitive performance.
Beyond 5-oxoproline, the study identified other metabolites with significant causal links. P-acetamidophenylglucuronide showed a positive association, while dihomo-linoleate (20:2n6) was negatively associated with intelligence. The analysis also highlighted the broader importance of the alpha-linolenic acid and linoleic acid metabolism pathways, suggesting that specific lipid processing mechanisms are integral to cognitive health.
Discussion
The robust link between 5-oxoproline and intelligence is particularly compelling because this metabolite has previously been explored as a potential "nootropic" or smart drug. This study provides the first rigorous genetic evidence to support its role in cognitive function. The researchers identified a specific genetic anchor for this effect: the SNP rs11986602, located near the EXOSC4 gene. This gene is involved in RNA processing and pathways that regulate neuronal excitability, offering a potential biological target for future cognitive research.
Interestingly, while 5-oxoproline was strongly linked to raw cognitive ability, it did not show a significant association with educational attainment or income. This suggests that while metabolic factors may boost innate "brain power," external social and environmental factors remain the primary drivers of academic and professional success.
Conclusion
By bridging the gap between genomics and metabolomics, this study identifies 5-oxoproline as a key metabolic driver of human intelligence. These findings not only enhance our understanding of the biological basis of cognition but also point toward potential metabolic interventions that could support brain health and cognitive development in the future.
Summary updated